ArticleBone marrow transplantation2026
Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.
Patrizia Chiusolo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it